Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
SHH: 603392.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zhiming Jiang
- Employees
- 3,790
- Headquarters
- Beijing, China
- IPO year
- 2020
- Market cap
- CN¥54.1B
- Website
- https://www.ystwt.com
Loading 603392…
Loading profile data…Frequently asked questions about 603392
What does Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) do?
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automa...
Where does 603392.SS trade?
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) trades on the Shanghai Stock Exchange.
What sector is 603392.SS in?
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.?
Zhiming Jiang is the chief executive officer of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS).
Where is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. headquartered?
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China.
Does 603392.SS pay a dividend?
Yes — Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) paid a trailing twelve-month dividend of CNY 0.32 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603392.SS go public?
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) completed its initial public offering in 2020.